Gyon Technologies Capital Management, LP Insulet Corp Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$194.8 - $275.7 $570,374 - $807,249	-2,928 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$255.32 - $318.29 $507,576 - $632,760	1,988 Added 211.49%	2,928 $779,000
Q3 2021 Nov 18, 2021	SELL	$260.36 - $307.27 $446,257 - $526,660	-1,714 Reduced 64.58%	940 $267,000
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $287,989 - $388,284	1,277 Added 92.74%	2,654 $729,000
Q1 2021 May 17, 2021	SELL	$235.95 - $293.05 $459,394 - $570,568	-1,947 Reduced 58.57%	1,377 $359,000
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $717,884 - $883,818	3,324 New	3,324 $850,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.